Loading...
•
Apr 01, 2023
Thermo Fisher Q1 2023 Earnings Report
Thermo Fisher Scientific's financial performance remained strong in Q1 2023, marked by strategic advancements and innovation.
Key Takeaways
Thermo Fisher Scientific reported a revenue of $10.71 billion, a 9% decrease compared to the same quarter last year. Core organic revenue growth was 6%. GAAP EPS was $3.32, and adjusted EPS was $5.03. The company launched innovative products, strengthened partnerships, and progressed towards renewable energy goals.
Revenue reached $10.71 billion, reflecting a 9% decrease year-over-year, with a core organic revenue growth of 6%.
GAAP diluted earnings per share (EPS) was reported at $3.32.
Adjusted EPS stood at $5.03.
The company actively deployed capital, including $3.0 billion in stock repurchases and a 17% dividend increase.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide updates on its 2023 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income